Canadian journal of physiology and pharmacologyAnimalsReceptorSerotonin5-HT2ARats
New hypoglycemic effects of indorenate mediated by the 5-HT1a and 5-HT2a receptors: in vivo and in silico studies.
Abraham Giacoman-Martínez, Julio César Almanza-Pérez, Francisco Javier Alarcón-Aguilar, Wendoline Rosiles-Alanís, Santiago Villafaña, Rodrigo Romero-Nava, Karla Aidee Aguayo-Cerón, Fengyang Huang, Enrique Hong
Published: 202610.1139/cjpp-2025-0027
Abstract
The treatment of metabolic syndrome (MS), characterized by type 2 diabetes, obesity, dyslipidemias, and cardiovascular problems, requires integral treatment. In addition to its central activity, serotonin also has peripheral effects, implying regulat…
Preview only. Read the full abstract at the source